Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-26

Clinical Trial Update: Study of the Safety of Intravenous Artesunate [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the safety of intravenous artesunate for malaria and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (intravenous) (artesunate)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria, Malaria, Cerebral | Phase 1 | Status: COMPLETED